Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis
- PMID: 32409511
- DOI: 10.1136/jmedgenet-2020-106866
Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis
Abstract
Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with phenotypic and genetic heterogeneity. Approximately 10% of cases are familial, while remaining cases are classified as sporadic. To date, >30 genes and several hundred genetic variants have been implicated in ALS.
Methods: Seven hundred and fifty-seven sporadic ALS cases were recruited from Australian neurology clinics. Detailed clinical data and whole genome sequencing (WGS) data were available from 567 and 616 cases, respectively, of which 426 cases had both datasets available. As part of a comprehensive genetic analysis, 853 genetic variants previously reported as ALS-linked mutations or disease-associated alleles were interrogated in sporadic ALS WGS data. Statistical analyses were performed to identify correlation between clinical variables, and between phenotype and the number of ALS-implicated variants carried by an individual. Relatedness between individuals carrying identical variants was assessed using identity-by-descent analysis.
Results: Forty-three ALS-implicated variants from 18 genes, including C9orf72, ATXN2, TARDBP, SOD1, SQSTM1 and SETX, were identified in Australian sporadic ALS cases. One-third of cases carried at least one variant and 6.82% carried two or more variants, implicating a potential oligogenic or polygenic basis of ALS. Relatedness was detected between two sporadic ALS cases carrying a SOD1 p.I114T mutation, and among three cases carrying a SQSTM1 p.K238E mutation. Oligogenic/polygenic sporadic ALS cases showed earlier age of onset than those with no reported variant.
Conclusion: We confirm phenotypic associations among ALS cases, and highlight the contribution of genetic variation to all forms of ALS.
Keywords: genetics; molecular genetics; motor neurone disease; neurosciences.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Identity by descent analysis identifies founder events and links SOD1 familial and sporadic ALS cases.NPJ Genom Med. 2020 Aug 7;5:32. doi: 10.1038/s41525-020-00139-8. eCollection 2020. NPJ Genom Med. 2020. PMID: 32789025 Free PMC article.
-
Genetic variability in sporadic amyotrophic lateral sclerosis.Brain. 2023 Sep 1;146(9):3760-3769. doi: 10.1093/brain/awad120. Brain. 2023. PMID: 37043475 Free PMC article.
-
Rare Variants in Neurodegeneration Associated Genes Revealed by Targeted Panel Sequencing in a German ALS Cohort.Front Mol Neurosci. 2016 Oct 13;9:92. doi: 10.3389/fnmol.2016.00092. eCollection 2016. Front Mol Neurosci. 2016. PMID: 27790088 Free PMC article.
-
New advances in Amyotrophic Lateral Sclerosis genetics: Towards gene therapy opportunities for familial and young cases.Rev Neurol (Paris). 2021 May;177(5):524-535. doi: 10.1016/j.neurol.2021.01.008. Epub 2021 Mar 31. Rev Neurol (Paris). 2021. PMID: 33810837 Review.
-
Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.Neuroepidemiology. 2021;55(5):342-353. doi: 10.1159/000516752. Epub 2021 Jul 9. Neuroepidemiology. 2021. PMID: 34247168 Review.
Cited by
-
Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family members.Eur J Hum Genet. 2025 Jan;33(1):7-13. doi: 10.1038/s41431-024-01718-4. Epub 2024 Nov 5. Eur J Hum Genet. 2025. PMID: 39501102 Free PMC article. Review.
-
Recent Progress of Antisense Oligonucleotide Therapy for Superoxide-Dismutase-1-Mutated Amyotrophic Lateral Sclerosis: Focus on Tofersen.Genes (Basel). 2024 Oct 20;15(10):1342. doi: 10.3390/genes15101342. Genes (Basel). 2024. PMID: 39457466 Free PMC article. Review.
-
The integrated stress response in neurodegenerative diseases.Mol Neurodegener. 2025 Feb 19;20(1):20. doi: 10.1186/s13024-025-00811-6. Mol Neurodegener. 2025. PMID: 39972469 Free PMC article. Review.
-
Mutation and clinical analysis of the CLCC1 gene in amyotrophic lateral sclerosis patients from Central South China.Ann Clin Transl Neurol. 2024 Jan;11(1):79-88. doi: 10.1002/acn3.51934. Epub 2023 Nov 2. Ann Clin Transl Neurol. 2024. PMID: 37916886 Free PMC article.
-
Identity by descent analysis identifies founder events and links SOD1 familial and sporadic ALS cases.NPJ Genom Med. 2020 Aug 7;5:32. doi: 10.1038/s41525-020-00139-8. eCollection 2020. NPJ Genom Med. 2020. PMID: 32789025 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous